C3.ai, Inc.

AI Q4 2026

Reported: 2026-06-05

C3 AI’s stock fell 5.4% after earnings as investors reacted negatively to the disappointing sales execution and a continued need for deep restructuring, signaling persistent challenges in driving growth despite significant cost cuts.

Key takeaways

The company has reduced headcount by about 35%, cutting approximately $135 million annually in operating costs.
Management emphasized a comprehensive restructuring across sales, products, services, and corporate functions to address what it described as “unspeakably horrible” sales performance.
New leadership has been installed across key divisions, including sales and federal segments, to improve execution and customer success.
The company highlighted adoption of AI tools to increase productivity broadly but provided no clear evidence of near-term sales acceleration or improved revenue trends.
Despite the capital sufficiency to avoid financing concerns, the outlook remains cautious given the depth of operational overhaul required.

View recap

Broadcom Inc.

AVGO Q2 2026

Reported: 2026-06-05

Shares tumbled 13% as investors were disappointed by cautious commentary on the software segment and a tempered outlook for AI semiconductor scaling despite record revenue; the sharp multiple contraction suggests concern over margin sustainability and execution risks ahead.

Key takeaways

Q2 total revenue hit a record $22.2 billion, driven by AI semiconductor revenue of $10.8 billion, up 143% year-over-year, with strong bookings over $30 billion signaling solid demand.
Semiconductor segment revenue grew 79% YoY, with networking and XPUs contributing significantly, though non-AI semiconductors showed modest 6% growth amid seasonal wireless declines.
Infrastructure software revenue rose 9% YoY to $7.2 billion, meeting guidance but lacking impressive acceleration, with ARR growth of 17%; management forecasts only 31% software growth in Q3.
Operating margins remained elevated at 67% (adjusted EBITDA 69%), but concerns linger about sustaining such exceptionally high margins as AI investments scale rapidly.
Q3 semiconductor revenue guidance of $20.5 billion (up 124%) and AI semiconductor revenue acceleration to $16 billion are positive but may be offset by cautious tone on future execution and AI software adoption risks.

View recap

Five Below, Inc.

FIVE Q1 2026

Reported: 2026-06-05

The stock declined 12.8% as investors reacted negatively to cautious commentary on the macro environment and implied deceleration risks despite reported strong sales and earnings growth.

Key takeaways

Reported first quarter sales rose nearly 33% to $1.3 billion, driven by 23% comp growth and 49 net new stores added.
Adjusted EPS grew over 2.5x year-over-year to $2.22 per share.
Broad-based comp strength with 15 of 18 departments positive, notably games and toys.
Management acknowledged a more challenging macro environment ahead and indicated raised full-year guidance includes cautious assumptions.
Despite operational execution and sales momentum, shares fell sharply likely reflecting investor skepticism about sustainability and margin pressures going forward.

View recap

Macy's, Inc.

M Q1 2026

Reported: 2026-06-05

Macy’s shares rose 6.3% post-earnings, supported by better-than-expected comparable sales and adjusted EPS, reflecting tangible early benefits from the Bold New Chapter strategy across nameplates and channels.

Key takeaways

Enterprise-wide comparable sales growth of 3.0%, the strongest first quarter since 2022; go-forward Macy’s tracks slightly higher at 3.1%.
Macy’s nameplate comps grew 1.6%, led by Reimagine locations which expanded to 200 stores and posted 2.4% comp growth.
Bloomingdale’s delivered a standout 10.2% comp increase, marking its highest first-quarter sales ever.
Adjusted EPS of $0.13 came in above the high end of prior guidance, driven by sales strength and expense management.
Mixed category trends with strong performance in watches, petites, dresses, and accessories offset by softness in big-ticket home furniture and plus-size apparel.

View recap

Medtronic plc

MDT Q4 2026

Reported: 2026-06-05

Shares rallied 11.1% as investors responded positively to strong organic revenue growth and robust execution in high-growth platforms, particularly in Cardiac Ablation Solutions (CAS) and advances in surgical robotics.

Key takeaways

Q4 revenue reached $9.8 billion, up 6.6% organically and 9.9% reported, marking the strongest top-line performance in a decade.
Adjusted EPS was $1.55 in Q4 and $5.53 for fiscal year 2026, reflecting disciplined operational execution.
CAS grew 78% globally, driven by PFA’s 145% growth and an expanded U.S. installed base up 40% sequentially.
Symplicity, the minimally invasive hypertension treatment, is annualizing at $100 million with growing physician adoption and procedure volumes.
Hugo surgical robotics procedures grew 2 to 3 times faster than the market, with recent U.S. rollout and promising early clinical feedback.

View recap

Ollie's Bargain Outlet Holdings, Inc.

OLLI Q1 2026

Reported: 2026-06-05

Shares fell 6% as investors were disappointed by cautious commentary on consumer traffic and category deceleration amid unseasonable weather and elevated fuel prices, which pressured key categories and led to trip consolidation.

Key takeaways

Traffic and sales trends weakened in regions affected by unseasonable weather and surging gas prices, particularly impacting lawn, garden, and summer furniture categories.
Lower-income customers, who comprise a significant portion of the base, showed increased trip consolidation due to higher fuel costs, weighing on store visits.
Management anticipates potential upside from pent-up demand in weather-sensitive categories but remains cautious on near-term headwinds.
The loyalty program expanded 13% to 17.5 million members, supporting a core customer base contributing over 80% of sales.
Completed warehouse execution system upgrade in Texas distribution center; ongoing expansions aim to support a network capacity of 850+ stores.

View recap

Petco Health and Wellness Company, Inc.

WOOF Q1 2026

Reported: 2026-06-05

Shares fell 3.0% following Q1 results as investors appeared cautious despite management’s positive framing, likely due to concerns around modest comp improvement and an overly optimistic outlook that failed to sufficiently address margin pressures or segment-specific weaknesses.

Key takeaways

The company reported a return to positive comps but failed to show strong acceleration, indicating modest improvement.
Margins showed some expansion but the details suggest pressure remains, especially given investments in new product launches and services.
The consumables business improved, driven by cat products and fresh frozen offerings, yet these were early innings of a longer transformation.
Services, including vet hospitals and grooming, remain growth engines, but meaningful hospital expansion is deferred to 2027.
Management reaffirmed full-year outlook without adjustments, which may have seemed cautious given soft early results and lingering execution risk.

View recap

Earnings Recaps

C3.ai, Inc.

Broadcom Inc.

Five Below, Inc.

Macy's, Inc.

Medtronic plc

Ollie's Bargain Outlet Holdings, Inc.

Petco Health and Wellness Company, Inc.

Community

Earnings Recaps

C3.ai, Inc.

Broadcom Inc.

Five Below, Inc.

Macy's, Inc.

Medtronic plc

Ollie's Bargain Outlet Holdings, Inc.

Petco Health and Wellness Company, Inc.

Community

Trending This Week

Notifications